Development of the molecular targeted therapy for allergic dermatitis
Development of the molecular targeted therapy for allergic dermatitis
批准号:
25293091
负责人:
SHIBUYA Kazuko
金额:
$11.07万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2013
资助国家:
日本
项目状态:
已结题
起止时间:
2013-04-01 至 2016-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0112415
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Nagumo Y, Iguchi-Manaka A, Yamashita-Kanemaru Y, Abe F, Bernhardt G, Shibuya A, Shibuya K]
通讯作者:
Shibuya K
癌患者血清における可溶型CD155の上昇
癌症患者血清中可溶性 CD155 升高
DOI:
--
发表时间:
2015
期刊:
影响因子:
--
作者:
[井口研子, 渋谷彰, 渋谷和子]
通讯作者:
渋谷和子
CD155 (PVR/Necl5) mediates a costimulatory signal in CD4+ T cells and regulates allergic inflammations.
CD155 (PVR/Necl5) 介导 CD4 T 细胞中的共刺激信号并调节过敏性炎症。
DOI:
--
发表时间:
2015
期刊:
J Immunol
影响因子:
4.4
作者:
[Yamashita Y, Takahashi Y, Wang Y, Tahara-Hanaoka S, Honda S, Bernhardt G, Shibuya A, Shibuya K.]
通讯作者:
Shibuya K.
Establishment and Characterization of a Novel Anti-DNAM-1 Monoclonal Antibody
新型抗 DNAM-1 单克隆抗体的建立和表征
DOI:
10.1089/mab.2012.0083
发表时间:
2013
期刊:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
影响因子:
--
作者:
[Yamashita Y, Abe F, Hirochika R, Tahara-Hanaoka S, Shibuya A, Shibuya K.]
通讯作者:
Shibuya K.
Fca/mR (CD351) regulates inflammatory responses of marginal zone B cells against experimental septic shock.
Fca/mR (CD351) 调节边缘区 B 细胞针对实验性感染性休克的炎症反应。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[Honda S, Yoshizawa Y, Sato K, Fujimoto M, Nakahashi-Oda C, Tahara-Hanaoka S, Shibuya K, Shibuya A.]
通讯作者:
Shibuya A.
共 19 条
Development of the molecular targeted therapy for the chronic rejection after renal transplantation that control immunological memory
-
批准号:26670575
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:SHIBUYA Kazuko
-
依托单位:
Development of the novel molecular target therapy for the graft versus host disease (GVHD) using the humanized mice
-
批准号:24659176
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:SHIBUYA Kazuko
-
依托单位:
Development of a novel tumor immunotherapy that targets the soluble poliovirus receptor
-
批准号:22390073
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2010
-
负责人:SHIBUYA Kazuko
-
依托单位:
A role of LFA-1 in the development of autoreactive Th17 cells
-
批准号:19390270
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2007
-
负责人:SHIBUYA Kazuko
-
依托单位:
Development of a novel molecular therapy for rheumatoid arthritis by regulation of Th1/Th2 differentiation
-
批准号:14370167
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:2002
-
负责人:SHIBUYA Kazuko
-
依托单位:
海外基金